Etoshine 60mg Tablet

About

Etoricoxib, the active ingredient in Etoshine 60mg Tablet, is a selective cyclooxygenase-2 (COX-2) inhibitor belonging to the class of non-steroidal anti-inflammatory drugs (NSAIDs). It works by selectively blocking the COX-2 enzyme, which is responsible for producing prostaglandins that cause pain and inflammation. By inhibiting COX-2, Etoricoxib effectively reduces pain, swelling, and stiffness associated with various inflammatory conditions. This selective action aims to minimize gastrointestinal side effects often associated with non-selective NSAIDs, which inhibit both COX-1 and COX-2 enzymes.

This medication is prescribed for the symptomatic relief of chronic inflammatory conditions and acute pain. Its therapeutic effects are primarily anti-inflammatory, analgesic, and antipyretic. The 60mg dosage is typically used for conditions requiring moderate pain and inflammation control, providing sustained relief over a prolonged period.

Uses

• Relief of pain and inflammation in osteoarthritis.
• Management of symptoms in rheumatoid arthritis.
• Treatment of ankylosing spondylitis.
• Short-term treatment of acute gouty arthritis.

Directions For Use

Take this medicine as directed by your doctor, usually once daily. Swallow the tablet whole with water, with or without food.

Benefits

• Effective relief from pain and inflammation.
• Reduces joint stiffness and swelling.
• Improves physical function and mobility.
• Selective COX-2 inhibition, potentially lower GI risk.
• Provides sustained analgesic effect.
• Suitable for chronic inflammatory conditions.

Side Effects

• Headache
• Dizziness
• Nausea
• Dyspepsia
• Abdominal pain
• Edema (fluid retention)
• Hypertension (high blood pressure)
• Palpitations
• Fatigue
• Flu-like symptoms
• Rash
• Heartburn

Safety Measures

• Alcohol - Concurrent use of alcohol with Etoricoxib may increase the risk of gastrointestinal irritation or bleeding. It is advisable to limit alcohol intake.
• Pregnancy - Etoricoxib is generally not recommended during pregnancy, especially in the third trimester, due to potential risks to the fetus, including premature closure of the ductus arteriosus and renal dysfunction. Consult a doctor.
• Breastfeeding - Etoricoxib is excreted in breast milk. It is advisable to avoid use during breastfeeding or consult a healthcare professional to weigh the benefits against potential risks to the infant.
• Liver - Use with caution in patients with mild to moderate hepatic impairment; dose adjustment may be necessary. It is contraindicated in severe liver disease. Regular monitoring of liver function is recommended.
• Kidney - Use with caution in patients with mild to moderate renal impairment; dose adjustment may be necessary. It is contraindicated in severe kidney disease. Regular monitoring of kidney function is recommended.
• Lung - Patients with a history of asthma, especially aspirin-sensitive asthma, should use Etoricoxib with caution as it may precipitate bronchospasm.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.